cimadronate has been researched along with Milk-Alkali Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gossman, WL; Oldfield, E; Van Brussel, EM; Wilson, SR | 1 |
| Eto, S; Fukumoto, S; Matsumoto, T; Nawata, H; Ogata, E; Onaya, T; Takebe, K | 1 |
| Higuchi, S; Ikeda, K; Ogata, E; Oiso, Y; Tomita, A; Uchida, T; Usui, T; Watanabe, T | 1 |
| Fukushima, S; Kokubo, S; Shirahata, A; Takahashi, K; Teramura, K; Usuda, S | 1 |
| Iga, T; Ohno, Y; Ohtani, H; Sato, H; Sawada, Y; Takahashi, K; Tsuchiya, F; Usu, T; Yamada, Y | 1 |
1 trial(s) available for cimadronate and Milk-Alkali Syndrome
| Article | Year |
|---|---|
Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Chromatography, High Pressure Liquid; Diphosphonates; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Hypercalcemia; Infusions, Intravenous; Male; Middle Aged | 1997 |
4 other study(ies) available for cimadronate and Milk-Alkali Syndrome
| Article | Year |
|---|---|
Hydronium (cycloheptylammonio)methylene-1,1-bisphosphonate (hydronium incadronate).
Topics: Bone Resorption; Crystallography, X-Ray; Diphosphonates; Hydrogen Bonding; Hypercalcemia; Models, Molecular; Structure-Activity Relationship | 2003 |
Treatment of malignancy-associated hypercalcemia with YM175, a new bisphosphonate: elevated threshold for parathyroid hormone secretion in hypercalcemic patients.
Topics: Adult; Aged; Aged, 80 and over; Calcium; Diphosphonates; Female; Humans; Hypercalcemia; Male; Middle Aged; Neoplasms; Parathyroid Hormone; Regression Analysis | 1994 |
Effects of YM175, a new-generation bisphosphonate, on hypercalcemia induced by tumor-derived bone resorbing factors in rats.
Topics: Animals; Bone Resorption; Diphosphonates; Hypercalcemia; Interleukin-1; Male; Models, Biological; Neoplasms, Experimental; Parathyroid Hormone-Related Protein; Proteins; Rats; Rats, Wistar | 1998 |
Pharmacokinetic and pharmacodynamic analysis of the antihypercalcemic effect of incadronate disodium in rats.
Topics: Animals; Bone and Bones; Calcium; Carcinoma, Squamous Cell; Diphosphonates; Humans; Hypercalcemia; Injections, Intravenous; Models, Biological; Models, Chemical; Mouth Neoplasms; Osteoclasts; Rats | 2001 |